Optimal Scan Time of (18)F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report

Positron emission tomography (PET)/computed tomography (CT)–guided radiofrequency ablation (RFA) has become a major treatment approach for small tumors. Identifying this quantitative dynamic (18)F-2-fluoro-2-deoxy-d-glucose ((18)F-FDG) activity at the primary lesion can minimize misdiagnosis and all...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen-Qian, Fu, Yi-Li, Hu, Bin, Chen, Shuo, Yang, Min-Fu, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616549/
https://www.ncbi.nlm.nih.gov/pubmed/26091453
http://dx.doi.org/10.1097/MD.0000000000000884
_version_ 1782396659295059968
author Zhang, Wen-Qian
Fu, Yi-Li
Hu, Bin
Chen, Shuo
Yang, Min-Fu
Li, Hui
author_facet Zhang, Wen-Qian
Fu, Yi-Li
Hu, Bin
Chen, Shuo
Yang, Min-Fu
Li, Hui
author_sort Zhang, Wen-Qian
collection PubMed
description Positron emission tomography (PET)/computed tomography (CT)–guided radiofrequency ablation (RFA) has become a major treatment approach for small tumors. Identifying this quantitative dynamic (18)F-2-fluoro-2-deoxy-d-glucose ((18)F-FDG) activity at the primary lesion can minimize misdiagnosis and allow an opportunity to reintervene. Here, we report 3 patients with nonsmall cell lung cancer (NSCLC) who underwent the ablative therapy with split-dose (18)F-FDG fused PET/CT scans for early identification of residual tumors and follow-up evaluation of treatment. Our results indicate that reliable post-RFA imaging follow-up is critical in fast and efficient assessment of complete tumor resection in patients experienced the ablation procedure.
format Online
Article
Text
id pubmed-4616549
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-46165492015-10-27 Optimal Scan Time of (18)F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report Zhang, Wen-Qian Fu, Yi-Li Hu, Bin Chen, Shuo Yang, Min-Fu Li, Hui Medicine (Baltimore) 5700 Positron emission tomography (PET)/computed tomography (CT)–guided radiofrequency ablation (RFA) has become a major treatment approach for small tumors. Identifying this quantitative dynamic (18)F-2-fluoro-2-deoxy-d-glucose ((18)F-FDG) activity at the primary lesion can minimize misdiagnosis and allow an opportunity to reintervene. Here, we report 3 patients with nonsmall cell lung cancer (NSCLC) who underwent the ablative therapy with split-dose (18)F-FDG fused PET/CT scans for early identification of residual tumors and follow-up evaluation of treatment. Our results indicate that reliable post-RFA imaging follow-up is critical in fast and efficient assessment of complete tumor resection in patients experienced the ablation procedure. Wolters Kluwer Health 2015-06-19 /pmc/articles/PMC4616549/ /pubmed/26091453 http://dx.doi.org/10.1097/MD.0000000000000884 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5700
Zhang, Wen-Qian
Fu, Yi-Li
Hu, Bin
Chen, Shuo
Yang, Min-Fu
Li, Hui
Optimal Scan Time of (18)F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report
title Optimal Scan Time of (18)F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report
title_full Optimal Scan Time of (18)F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report
title_fullStr Optimal Scan Time of (18)F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report
title_full_unstemmed Optimal Scan Time of (18)F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report
title_short Optimal Scan Time of (18)F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report
title_sort optimal scan time of (18)f-fdg pet in identifying therapeutic efficacy secondary to radiofrequency ablation of lung cancer: case report
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616549/
https://www.ncbi.nlm.nih.gov/pubmed/26091453
http://dx.doi.org/10.1097/MD.0000000000000884
work_keys_str_mv AT zhangwenqian optimalscantimeof18ffdgpetinidentifyingtherapeuticefficacysecondarytoradiofrequencyablationoflungcancercasereport
AT fuyili optimalscantimeof18ffdgpetinidentifyingtherapeuticefficacysecondarytoradiofrequencyablationoflungcancercasereport
AT hubin optimalscantimeof18ffdgpetinidentifyingtherapeuticefficacysecondarytoradiofrequencyablationoflungcancercasereport
AT chenshuo optimalscantimeof18ffdgpetinidentifyingtherapeuticefficacysecondarytoradiofrequencyablationoflungcancercasereport
AT yangminfu optimalscantimeof18ffdgpetinidentifyingtherapeuticefficacysecondarytoradiofrequencyablationoflungcancercasereport
AT lihui optimalscantimeof18ffdgpetinidentifyingtherapeuticefficacysecondarytoradiofrequencyablationoflungcancercasereport

Ejemplares similares